Edit Symbol List
ERES: Stock Quote & Summary Data
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 7.75 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 352,768 |
| Previous Close | $ 5.90 |
| 52 Wk High / Low | $ 8.50 / $ 3.86 |
| Shares Outstanding | 48,468,000 |
| Market Value | $ 281,114,400 |
| P/E Ratio | 22.31 |
| Forward P/E (1yr) | 19.67 |
| Earnings Per Share | $ 0.26 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.66 |
| NASDAQ Official Open Price: | $ 5.85 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 5.80 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About ERES?
Ask your question about about eResearch Technology Inc. (ERES) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
eResearchTechnology, Inc. (eRT), a Delaware corporation, was founded in 1977 to provide Cardiac Safety services to evaluate the safety of new drugs. eRT and its consolidated subsidiaries collectively are referred to as the “Company” or “we.” We provide technology and services that enable the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently. We are a market leader in providing centralized electrocardiographic services (Cardiac Safety services or EXPeRT® ECG services) and a leading provider of technology and services that streamline the clinical trials process by enabling our clients to evolve from traditional, paper-based methods to electronic processing using our EXPeRT® eClinical and EXPeRT® ePRO products and services. ... More ...
Links to all eResearch Technology Inc. (ERES) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for ERES |
||
|
Chairman Buys $6.4M Worth of Shaw Group - TheStreet 11/05/2009 10:03AM |
||
|
ERT Reports Third Quarter 2009 Results - PR Newswire 10/29/2009 4:05PM |
||
|
EResearchTechnology Q3 09 Earnings Conference Call At 5:00 PM - RTT News 10/29/2009 2:40PM |
||
|
ERT to Announce 2009 Third Quarter Results on October 29, 2009 - PR Newswire 10/21/2009 11:45AM |
||
|
EResearchTechnology To Present At UBS Global Life Sciences Conference; Webcast At 11:00 AM - RTT News 09/21/2009 10:27AM |
||
|
ERT to Present at UBS Global Life Sciences Conference on September 21, 2009 - PR Newswire 09/14/2009 4:02PM |
||
|
EResearchTechnology To Present At Baird''s 2009 Health Care Conference At 11:30 AM - RTT News 09/09/2009 11:15AM |



Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
1.69%
